Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C76H137N3O31 |
Molecular Weight | 1588.9025 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 28 / 28 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@H](O)CO)C(=O)OC(C)C)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC
InChI
InChIKey=NBMVYETVBIIWFF-AACOHXQBSA-N
InChI=1S/C76H137N3O31/c1-7-9-11-13-15-17-19-21-22-24-26-28-30-32-34-36-55(90)79-47(48(87)35-33-31-29-27-25-23-20-18-16-14-12-10-8-2)43-100-72-64(97)62(95)66(53(41-83)104-72)106-74-65(98)70(110-76(75(99)101-44(3)4)37-49(88)56(77-45(5)85)69(109-76)58(91)50(89)38-80)67(54(42-84)105-74)107-71-57(78-46(6)86)68(60(93)52(40-82)102-71)108-73-63(96)61(94)59(92)51(39-81)103-73/h33,35,44,47-54,56-74,80-84,87-89,91-98H,7-32,34,36-43H2,1-6H3,(H,77,85)(H,78,86)(H,79,90)/b35-33+/t47-,48+,49-,50+,51+,52+,53+,54+,56+,57+,58+,59-,60-,61-,62+,63+,64+,65+,66+,67-,68+,69+,70+,71-,72+,73-,74-,76-/m0/s1
Mipragoside (also known as AGF 44), an isopropyl ester of monosialoganglioside GM1 that was developed as an anti-inflammatory agent. The topical treatment by this drug improved symptoms of patients with vernal keratoconjunctivitis. Mipragoside was in phase I in Italy for the treatment of inflammation; however, this study was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8944090
Patients received either Mipragoside 0.5% aqueous ophthalmic gel or placebo four times a day for 2 weeks after a week of treatment with placebo.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000080643
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
6731
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105889
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
C170180
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
76966493
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
SUB08986MIG
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
IOR159KL0H
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY | |||
|
131129-98-1
Created by
admin on Fri Dec 15 15:45:43 GMT 2023 , Edited by admin on Fri Dec 15 15:45:43 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD